Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments.

Project Information

ElectroPros

Grant agreement ID: 813192

DOI 10.3030/813192

Project closed

EC signature date 27 July 2018

Start date 1 January 2019

End date 31 December 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 1 023 985,08

EU contribution € 1 023 985,08

Coordinated by

PHILIPS ELECTRONICS NEDERLAND BV
Netherlands

Deliverables

Other (5)

PhD degree award
Ethics approval
Conference visits
Recruitment completion
General section website on-line

Documents, reports (1)

Exploitation and dissemination plan

Publications

Peer reviewed articles (3)

Pulse Parameters and Thresholds for (ir)Reversible Electroporation on Hepatocellular Carcinoma Cells <i>in Vitro</i>

Author(s): K. H. K. Lindelauf; M. Baragona; M. Baumann; R. T. H. Maessen; A. Ritter
Published in: Technology in Cancer Research & Treatment, Issue 2023 Jan-Dec, 2023, ISSN 1533-0338
Publisher: Sage
DOI: 10.1177/15330338221136694

Global sensitivity study for irreversible electroporation: Towards treatment planning under uncertainty

Author(s): Prashanth Lakshmi Narasimhan, Zoi Tokoutsi, Davide Baroli, Marco Baragona, Karen Veroy, Ralph Maessen, Andreas Ritter
Published in: Medical Physics, Issue 50(3), 2023, Page(s) 1290-1304, ISSN 2473-4209
Publisher: Wiley
DOI: 10.1002/mp.16220

Plant-based model for the visual evaluation of electroporated area after irreversible electroporation and its comparison to in-vivo animal data

Author(s): Kim. H. K. Lindelauf; Athul Thomas; Marco Baragona; Ali Jouni; Teresa Nolte; Federico Pedersoli; Joachim Pfeffer; Martin Baumann; Ralph. T. H. Maessen; Andreas Ritter
Published in: Science Progress, Issue 2023 Jan-Mar:106(1), 2023, ISSN 0036-8504
Publisher: Science Reviews Ltd.
DOI: 10.1177/00368504231156294